CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 301 enrolled
Drug / intervention
Computerized patient decision-aid +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02319525
NCT02319525N/ACompleted
CompareCT.gov

Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus

University of Alabama at Birmingham·interventional·Posted Dec 18, 2014·Updated Jul 18, 2017

In Brief

A clinical study evaluating Computerized patient decision-aid and Usual care (lupus pamphlet) for Systemic Lupus Erythematosus. Completed, enrolled 301 participants across 1 site.

Detailed Summary

The study will compare the efficacy of the usual education materials to individualized computerized decision guide on decision conflict of patients with lupus nephritis making treatment decisions regarding immunosuppressive therapies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Lupus Erythematosus
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 18, 2014
Enrollment StartJan 1, 2014
Primary CompletionNov 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.5 years ago

Interventions

Computerized patient decision-aidother

The decision-aid contained information regarding lupus and lupus nephritis, its impact on patient lives and benefits and harms of lupus nephritis treatments, focused on immunosuppressive medications compared to each other. The content of the decision-aid allowed individualization based on patient preference for details on certain aspects, as well as the desire to view additional, optional sections of the decision-aid.

Usual care (lupus pamphlet)other

Patient received the standard handout/pamphlet from a non-profit organization (American College of Rheumatology \[ACR\]) regarding lupus and its treatments, that explained risks and benefits of various treatments